Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Biogen Inc shares valued at $1,314,142 were sold by SHERWIN STEPHEN A on Mar 07 ’25. At $150.02 per share, SHERWIN STEPHEN A sold 8,760 shares. The insider’s holdings dropped to 11,318 shares worth approximately $1.37 million following the completion of this transaction.
Also, STEPHEN A SHERWIN purchased 8,760 shares, netting a total of over 1,290,961 in proceeds.
Before that, Singhal Priya had sold 110 shares from its account. In a trade valued at $17,293, the Head of Development traded Biogen Inc shares for $157.21 each. Upon closing the transaction, the insider’s holdings decreased to 110 shares, worth approximately $0.66 million.
As published in a research note from HSBC Securities on April 28, 2025, Biogen Inc [BIIB] has been rated down from a Buy to a Hold and the price target has been revised to $118. Analysts at Argus downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in early April. As of February 11, 2025, Bernstein has initiated its “Mkt perform” rating for BIIB. Earlier on January 02, 2025, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for BIIB stock which previously was a “an Overweight”.
Analyzing BIIB Stock Performance
During the last five days, there has been a surge of approximately 1.19%. Over the course of the year, Biogen Inc shares have dropped approximately -20.92%. Shares of the company reached a 52-week high of $157.09 on 03/10/25 and a 52-week low of $110.04 on 04/09/25. A 50-day SMA is recorded $132.30, while a 200-day SMA reached $165.58.
Support And Resistance Levels for Biogen Inc (BIIB)
According to the 24-hour chart, there is a support level at 117.61, which, if violated, would cause prices to drop to 114.28. In the upper region, resistance lies at 124.80. The next price resistance is at 128.66. RSI (Relative Strength Index) is 44.53 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.26, which suggests the price will increase in the coming days. Percent R is at 33.51%, indicating low price movement. Stochastics %K at selling indicates that the stock is to be held.
